Federal Register of Legislation - Australian Government

Primary content

PB 53 of 2010 Specifications as made
This Determination amends the National Health Act (Pharmaceutical Benefits - Early Supply) - specification under subsection 84AAA(2) Instrument 2009 (No. PB 30 of 2009) to provide pharmaceutical benefits that can be resupplied inside 20 days on the one prescription.
Administered by: Health
Registered 26 May 2010
Tabling HistoryDate
Tabled HR31-May-2010
Tabled Senate15-Jun-2010
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

 

COMMONWEALTH OF AUSTRALIA

Instrument number PB 53 of 2010

National Health Act (Pharmaceutical Benefits – Early Supply) Amendment June 2010 - Specification Under Subsection 84AAA(2)

 

Amendment determination under subsection 84AAA(2) of the National Health Act 1953

 

I, Felicity McNeill, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

 

Dated                    20      May 2010

 

 

FELICITY MCNEILL

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

 

 

 

Amendment determination — Pharmaceutical Benefits - Early Supply

 

 

1          Name of Instrument

 

(1)           This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment June 2010 - specification under subsection 84AAA(2).

 

(2)           This Instrument may also be cited as “No. PB 53 of 2010”.


 

2          Commencement

 

This Instrument commences on 1 June 2010.

 

 

3          Amendment of PB 30 of 2009

 

Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009, PB 30 of 2009.

 


Schedule 1        Amendments

[1]                                  Schedule 1, after item dealing with Alendronic acid with colecalciferol

insert in the columns in the order indicated:

 

Alendronic acid with colecalciferol and calcium

Pack containing 4 tablets containing alendronic acid 70 mg (as alendronate sodium) with 140 micrograms colecalciferol and 48 tablets calcium 500 mg (as carbonate)

Oral

1

5

 

 

[2]                                  Schedule 1, item dealing with Clopidogrel

insert in the columns in the order indicated:

 

 

Tablet 75 mg (as besilate)

Oral

28

5

 

 

[3]                                  Schedule 1, item dealing with Mesalazine

insert in the columns in the order indicated:

 

 

Tablet 1.2 g (prolonged release)

Oral

60

5

 

 

[4]                                  Schedule 1, after item dealing with Perindopril

insert in the columns in the order indicated:

 

Perindopril with amlodipine

Tablet containing 5 mg perindopril arginine with 5 mg amlodipine (as besylate)

Oral

30

5

 

Tablet containing 5 mg perindopril arginine with 10 mg amlodipine (as besylate)

Oral

30

5

 

Tablet containing 10 mg perindopril arginine with 5 mg amlodipine (as besylate)

Oral

30

5

 

Tablet containing 10 mg perindopril arginine with 10 mg amlodipine (as besylate)

Oral

30

5